GlassScriptPhysician profile
Jenna K Whitehead
NPI 1497096523
$2,632.57
in general payments reported to CMS, 2019-2025
32 companies · $535 in 2025
The $535 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $631 · 2022: $571 · 2023: $422 · 2024: $473 · 2025: $535.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,430.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,430.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $476.91 | 2021-2025 | |
| Novo Nordisk INC | $305.00 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $290.27 | 2021-2025 | Farxiga, Airsupra, Breztri |
| Lilly USA, LLC | $222.31 | 2021-2025 | Zepbound, Mounjaro, Jardiance |
| Amgen INC. | $169.98 | 2021-2025 | Repatha, Otezla, Otezla |
| Boehringer Ingelheim Pharmaceuticals, INC. | $166.58 | 2021-2025 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $124.38 | 2021-2023 | |
| Glaxosmithkline, LLC. | $118.37 | 2022-2024 | Trelegy Ellipta, Arexvy |
| Pfizer INC. | $117.87 | 2023-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $75.32 | 2021-2022 | |
| Corium, LLC | $72.09 | 2023 | Azstarys |
| Dexcom, INC. | $45.17 | 2023-2025 | Dexcom G6 Transmitter |
| Takeda Pharmaceuticals U.S.A., INC. | $43.70 | 2021-2022 | |
| Axonics, INC. | $37.98 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $33.68 | 2022 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ibsa Pharma INC. | $31.76 | 2022 | |
| Tms Neurohealth Centers INC. | $28.60 | 2025 | Tms Neurohealth Centers INC. |
| Zealand Pharma US, INC. | $25.33 | 2021 | |
| Astellas Pharma US INC | $25.25 | 2024 | Veozah |
| Amneal Pharmaceuticals LLC | $24.97 | 2021-2022 | |
| Inspire Medical Systems, INC. | $22.42 | 2023 | Inspire |
| Noven Therapeutics, LLC | $21.17 | 2023 | Xelstrym |
| Teva Pharmaceuticals USA, INC. | $20.27 | 2021 | |
| Shield Therapeutics INC | $17.73 | 2022 | |
| Amarin Pharma, INC. | $17.00 | 2021 | |
| Lundbeck LLC | $15.32 | 2022 | |
| Ironshore Pharmaceuticals INC. | $15.01 | 2021 | |
| Insulet Corporation | $14.90 | 2022 | |
| Collegium Pharmaceutical, INC. | $13.98 | 2025 | Jornay Pm |
| Xeris Pharmaceuticals, INC. | $13.71 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $13.21 | 2021 | |
| Medtronic, INC. | $12.33 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jenna Whitehead listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.